10x Genomics, Inc. Weighted Average Number of Shares Outstanding, Basic from 2019 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
10x Genomics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2019 to Q3 2025.
  • 10x Genomics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 126M shares, a 3.95% increase year-over-year.
  • 10x Genomics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 120M shares, a 2.81% increase from 2023.
  • 10x Genomics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 117M shares, a 2.9% increase from 2022.
  • 10x Genomics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 114M shares, a 3.18% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)

10x Genomics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 126M +4.77M +3.95% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-07
Q2 2025 124M +3.69M +3.07% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-08
Q1 2025 123M +3.21M +2.69% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-09
Q4 2024 120M +3.29M +2.81% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-13
Q3 2024 121M +3M +2.55% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-07
Q2 2024 120M +3.36M +2.88% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-08
Q1 2024 119M +3.77M +3.26% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-09
Q4 2023 117M +3.31M +2.9% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-13
Q3 2023 118M +3.62M +3.17% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-29
Q2 2023 117M +3.13M +2.76% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 116M +2.65M +2.35% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 114M +3.51M +3.18% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-13
Q3 2022 114M +3.24M +2.92% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 114M +3.71M +3.38% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 113M +4.25M +3.91% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 110M +9.2M +9.09% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 111M +9.53M +9.41% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 110M +10.9M +11% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 109M +11.9M +12.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 101M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 101M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 99M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 96.8M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07

10x Genomics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 120M +3.29M +2.81% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-13
2023 117M +3.31M +2.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-13
2022 114M +3.51M +3.18% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-13
2021 110M +9.2M +9.09% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 101M +62.1M +159% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-16
2019 39.1M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.